+39 06 5782665
contact@donawa.com
Italy - UK - USA

MDCG issues guidance on In Vitro Diagnostic Classification Rules

  • Posted by: inetika
  • Category: GLOBAL NEWS

The European Commission’s Medical Device Coordination Group (MDCG) has published long-awaited guidance, MDCG 2020-16, that explains how to classify products for compliance with the EU’s In Vitro Diagnostics Regulation (IVDR, 2017/746).

The IVDR is replacing the classification system from the In Vitro Diagnostics Directive (IVDD, 98/79/EC) with a risk-based system, which will require the reclassification of many IVDs into higher classes, thus requiring the involvement of a Notified Body for the first time. The new regulation goes into effect on May 26, 2022, except for in vitro diagnostics that qualify for a grace implementation period that extends to May 27, 2024.

The new guidance offers numerous examples to help manufacturers understand how their IVDs should be classified for compliance with the regulation.

This website uses cookies and asks your personal data to enhance your browsing experience.